Taiwan FDA registration f2357be6dfde1e52b3160f998c3ee1d3
"Domini" acid flushing method to obtain the antibody reagent group on red blood cells
TW: "多明尼" 酸沖出法取得紅血球上之抗體試劑組
Taiwan·Risk Class 2·DOMINION BIOLOGICALS LIMITED·Registered Nov 10, 2005 – Nov 10, 2020CancelledRegistration details
- Analysis ID
- f2357be6dfde1e52b3160f998c3ee1d3
- Customs Code
- DHA00601459300
Company information
- Manufacturer
- DOMINION BIOLOGICALS LIMITED
- Manufacturer Country
- Canada
- Authorized Representative
- Y.H. BIOTEK CO., LTD.
Product details
- Intended Use
- Antibodies to red blood cells are obtained by acid flushing.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- import
Dates and status
- Registration Date
- Nov 10, 2005
- Expiry Date
- Nov 10, 2020
- Cancellation Date
- Aug 05, 2022
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Domini" acid flushing method to obtain the antibody reagent group on red blood cells in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f2357be6dfde1e52b3160f998c3ee1d3 and manufactured by DOMINION BIOLOGICALS LIMITED. The authorized representative in Taiwan is Y.H. BIOTEK CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices